You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Molecular Response

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Acute Lymphocytic Trial in Durham (Copanlisib)

Recruiting
  • Leukemia, Acute Lymphocytic
  • Durham, North Carolina
    Duke Cancer Center
Jun 28, 2022

CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

Recruiting
  • CML
  • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
  • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
    FUNDALEU
Jun 29, 2023

Atopic Dermatitis Trial in San Francisco (Dupilumab)

Recruiting
  • Atopic Dermatitis
  • San Francisco, California
    University of California, San Francisco
May 4, 2023

Genetic Change Trial in Zhengzhou (Gene evolution and molecular response under Bevacizumab treatment)

Recruiting
  • Genetic Change
  • Gene evolution and molecular response under Bevacizumab treatment
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Aug 21, 2022

Effect of Pharmacogenetics on Imatinib Plasma Level and Response

Active, not recruiting
  • Chronic Myeloid Leukemia
  • PCR
  • HPLC-UV
  • Assiut, Egypt
    South Egypt Cancer Institute
Aug 6, 2022

Ponatinib in CML Patients in Chronic Phase

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Therapeutic drug monitoring
  • Molecular Response
  • Cagliari, Italy
  • +4 more
Nov 3, 2023

According to Molecular Identification at Diagnosis

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Next Generation Sequencing (DNA and RNA)
  • (no location specified)
Oct 28, 2022

Crohn's Disease, Ulcerative Colitis Trial (Samples)

Not yet recruiting
  • Crohn's Disease
  • Ulcerative Colitis
  • Samples
  • (no location specified)
Feb 8, 2023

Depression, Psychosis, Anhedonia Trial in Chapel Hill (Transdermal Estradiol, Micronized Progesterone, Matching Placebo Patch)

Recruiting
  • Depression
  • +2 more
  • Transdermal Estradiol
  • +3 more
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill
Dec 20, 2022

Myeloid Leukemia, Chronic Trial in France (Glivec)

Terminated
Has Results
  • Myeloid Leukemia, Chronic
  • Bordeaux, France
  • +6 more
Nov 5, 2021

NSCLC Trial in Canada, United States (Pembrolizumab)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Baltimore, Maryland
  • +5 more
Apr 7, 2022

Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission, Chronic Myeloid Leukemia in Remission Trial

Recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Withdrawal
  • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Re-initiation
  • Houston, Texas
  • +3 more
Jan 25, 2022

Athletic Performance, Muscle Fatigue, Oxidative Stress Trial in Olomouc (Hydrogen rich water, Placebo)

Enrolling by invitation
  • Athletic Performance
  • +2 more
  • Hydrogen rich water
  • Placebo
  • Olomouc, Czechia
    Palacky University, Faculty of Physical Culture
Apr 11, 2023

Near Patient Molecular Testing in Sepsis

Active, not recruiting
  • Sepsis
  • Systemic Inflammatory Response Syndrome
    • Los Angeles, California
    • +2 more
    Jul 19, 2022

    Respiratory Viral Infections in Pediatric Transplant Recipients

    Recruiting
    • Hematopoietic Cell Transplant
    • +2 more
      • Little Rock, Arkansas
      • +4 more
      Jan 11, 2023

      Chronic Myeloid Leukemia, Chronic Phase Trial in Spain (Ponatinib 15 MG, Acetylsalicylic acid 100 MG)

      Recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • Ponatinib 15 MG
      • Acetylsalicylic acid 100 MG
      • L'Hospitalet De Llobregat, Barcelona, Spain
      • +12 more
      Feb 8, 2022

      Treatment in FH-deficient RCC Patients

      Recruiting
      • FH-Deficient RCC
      • +2 more
      • Laboratory analysis of samples
      • Shanghai, Shanghai, China
        Ethics Committee of Shanghai Renji Hospital
      Sep 6, 2022

      Response to Therapy and Breast Cancer Behavior

      Recruiting
      • Breast Cancer
      • biologic sample preservation procedure
      • +2 more
      • Chapel Hill, North Carolina
        Lineberger Comprehensive Cancer Center at University of North Ca
      Jun 8, 2022

      Seborrheic Dermatitis Trial in New York (Ruxolitinib 1.5% Cream)

      Recruiting
      • Seborrheic Dermatitis
      • Ruxolitinib 1.5% Cream
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Mar 15, 2023

      Chronic Myelogenous Leukemia - Chronic Phase Trial in United States (Nilotinib)

      Terminated
      Has Results
      • Chronic Myelogenous Leukemia - Chronic Phase
      • Los Angeles, California
      • +10 more
      Jul 26, 2021

      Response to First Line Treatment in Lichen Planus

      Enrolling by invitation
      • Lichen Planus, Oral
      • Lichen Planus of Vulva
      • No interventions were administered to the patients as a part of this study.
      • Aberdeen, Aberdeen, Scotland, United Kingdom
        University of Aberdeen
      Apr 8, 2022

      Head Neck Cancer Trial in Little Rock (Optical Spectroscopy)

      Not yet recruiting
      • Head and Neck Cancer
      • Optical Spectroscopy
      • Little Rock, Arkansas
        University of Arkansas for Medical Sciences
      Mar 14, 2022

      NSCLC Trial in Washington, Hackensack, Neptune (Nivolumab, Ipilimumab, Carboplatin)

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
      • Washington, District of Columbia
      • +2 more
      Jan 27, 2023

      Stage III Breast Cancer AJCC V7 Trial in Bergen (epirubicin/docetaxel sequential)

      Active, not recruiting
      • Stage III Breast Cancer AJCC V7
      • epirubicin/docetaxel sequential
      • Bergen, Norway
        Dept of Oncology
      Jun 24, 2022

      Inflammatory and Anti-Inflammatory Gene Expressions in Liver

      Active, not recruiting
      • Liver Transplant; Complications
      • +3 more
      • Molecular Immunology , gene expressions
      • Malatya, Turkey
        İnönü University
      May 2, 2023